BioInformant is honored to be a sponsor for the upcoming “Biorepositories and Sample Management Summit” in Boston, Massachussetts, over October 12-14, 2015. This 3-day event promises to be the most interactive biobanking community event of the year.
BioInformant is Honored to Sponsor the Perinatal Stem Cell Society Conference
BioInformant is  honored to be a sponsor for the upcoming “Perinatal Stem Cell Society Conference” in Aspen, Colorado, over March 2-4, 2016. This 3-day event will feature the world’s leading perinatal stem cell researchers, specializing in Amnion, Amniotic fluid, Cord Blood for Regenerative Medicine, Cord Tissue, and the Placenta. BioInformant’s sponsorship of the event is in collaboration with Save the Cord Foundation, as part of our partnership  to promote cord blood banking awareness around the world.
The Perinatal Stem Cell Society was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many disorders. It will be hosting a scientific program with topics covering all aspects of the perinatal stem cell field. Attendees are actively advancing perinatal stem cell research, and focused on paths towards treatment. [Read more…]
Stem Cells Delivered Intranasally Can Bypass the Blood-Brain Barrier to Treat Brain Disorders
In recent groundbreaking research, Dr. William H. Frey II (Director, Alzheimer’s Research Center) and Dr. Lusine Danielyan announced that they have discovered and patented that therapeutic cells, including adult stem cells, can be delivered to the brain using a noninvasive intranasal delivery method.
This non-invasive intranasal method for bypassing the blood-brain barrier can rapidly delivery and target therapeutic agents to the brain along the olfactory and trigeminal neural pathways while reducing systemic exposure and side effects. The intranasal insulin treatment discovered by Dr. Frey for Alzheimer’s disease has been shown in multiple clinical trials to improve memory in both Alzheimer’s patients and normal adults.
[Read more…]
Tasked with Meeting Increasingly Large Sales Goals for Your Stem Cell Company?
This was a major year for stem cells, as we saw the first ever induced pluripotent stem cell (iPSC) trial in humans, as well as several large mergers and acquisitions within the stem cell industry. One of the most prominent was the buyout of Life Technologies by industry behemoth Thermo Fisher Scientific.
There were also major technical advances that occurred, including notable advances made by scientists at the Harvard Stem Cell Institute (HSCI) toward the creation of human insulin-producing cells from human embryonic stem cells, as well as advances in the bio-fabrication of human tissues using 3-D cell printing technology, led by Guohao Dai of the Rensselaer Polytechnic Institute, among others.
[Read more…]
- « Previous Page
- 1
- …
- 16
- 17
- 18